EYPT vs NWSA · rev $1.2M vs rev $9.03B
Eyepoint Pharmaceuticals Inc (EYPT) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
NWSA (NWSA) common stock.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
EYPT currently screens at market cap $1.10B. NWSA currently screens at market cap $0.
Not investment advice. Open the EYPT and NWSA stock pages for the full models.
Not investment advice.